Abstract
Abstract Quinoxaline derivatives 4–11 were synthesized and evaluated for their in vitro growth inhibitory activities against liver carcinoma cell line (HEPG2) using the sulforhodiamine B assay. The synthesis was achieved by reaction of 2,3-dichloroquinoxalines 2a,b with 4-aminoacetophenone to give the corresponding compounds 3a,b. Claisen-Schmidt condensation reaction of 3a,b with furfuraldehyde gave enones 4a,b, which were transformed into pyridines 6a,b, 8a,b, isoxazolines 9a,b, pyrazolines 10a–d, and pyrimidines 11a,b via several synthetic routes. Virtual screening was carried out by molecular modeling evaluation of the designed compounds. Biological evaluation of the prepared compounds showed that most of the synthesized compounds exhibit more than 50% growth inhibitory.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
